CVRx (CVRX)
Implantable Barostim therapy improves symptoms for eligible heart-failure patients.
$2.81
vs last close−0.08 (−2.94%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 42 days
EPS estimate
−$0.49
Revenue estimate
$13.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.43−$0.53−$0.57−$0.49−$0.46−$0.50−$0.53Pending
Estimate−$0.37−$0.56−$0.52−$0.50−$0.42−$0.51−$0.52−$0.49
Surprise−16.2%+5.4%−9.6%+2.0%−9.5%+2.0%−1.0%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$15.3M$12.3M$13.6M$14.7M$16.0M$14.8M$15.7MPending
Estimate$15.2M$13.3M$14.4M$15.8M$15.8M$14.5M$15.5M$13.9M
Surprise+0.8%−7.3%−5.6%−6.7%+1.6%+1.9%+1.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.48 | — | — |
| Sep 2028 | −$0.46 | — | — |
| Jun 2028 | −$0.48 | — | — |
| Mar 2028 | −$0.48 | — | — |
| Dec 2027 | −$0.47 | — | — |
| Sep 2027 | −$0.46 | — | — |
| Jun 2027 | −$0.51 | — | — |
| Mar 2027 | −$0.51 | — | — |
| Dec 2026 | −$0.49 | — | — |
| Nov 2026 | −$0.49 | — | — |
| Aug 2026 | −$0.52 | −$0.53 | −1.0% |
| May 2026 | −$0.51 | −$0.50 | +2.0% |
| Feb 2026 | −$0.42 | −$0.46 | −9.5% |
| Nov 2025 | −$0.50 | −$0.49 | +2.0% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Jan 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Jan 2023 | |||
| Nov 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Aug 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.48 | — | — | $19.3M | — | — | — |
| Sep 2028 | −$0.46 | — | — | $18.0M | — | — | — |
| Jun 2028 | −$0.48 | — | — | $18.5M | — | — | — |
| Mar 2028 | −$0.48 | — | — | $17.9M | — | — | — |
| Dec 2027 | −$0.47 | — | — | $17.9M | — | — | — |
| Sep 2027 | −$0.46 | — | — | $17.1M | — | — | — |
| Jun 2027 | −$0.51 | — | — | $16.2M | — | — | — |
| Mar 2027 | −$0.51 | — | — | $15.3M | — | — | — |
| Dec 2026 | −$0.49 | — | — | $14.5M | — | — | — |
| Nov 4, 2026 | −$0.49 | — | — | $13.9M | — | — | — |
| Aug 6, 2026 | −$0.52 | −$0.53 | −1.0% | $15.5M | $15.7M | +1.0% | −59.8% |
| May 11, 2026 | −$0.51 | −$0.50 | +2.0% | $14.5M | $14.8M | +1.9% | −23.8% |
| Feb 12, 2026 | −$0.42 | −$0.46 | −9.5% | $15.8M | $16.0M | +1.6% | −13.0% |
| Nov 5, 2025 | −$0.50 | −$0.49 | +2.0% | $15.8M | $14.7M | −6.7% | +2.7% |
| Aug 4, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 4, 2025 | |||||||
| Oct 29, 2024 | |||||||
| Jul 29, 2024 | |||||||
| Apr 30, 2024 | |||||||
| Jan 25, 2024 | |||||||
| Oct 26, 2023 | |||||||
| Jul 25, 2023 | |||||||
| Apr 27, 2023 | |||||||
| Jan 26, 2023 | |||||||
| Nov 1, 2022 | |||||||
| Jul 28, 2022 | |||||||
| Apr 25, 2022 | |||||||
| Feb 15, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 9, 2021 | |||||||
| Aug 4, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 |